Gentag

Gentag is a health technology company developing next-generation wearable sensors and mobile diagnostic tools. Its focus is low-cost, thin smart skin patches that provide health readings directly to smartphones, supporting convenient at-home monitoring and helping address healthcare costs and medication compliance. The company describes disposable diagnostic patches for fever detection, diabetes and cardiac monitoring, and drug delivery. Its portfolio also includes skin-care patches, IoT sensors, biomarker technologies, modular sensors, and drug-compliance monitoring.

Gentag also features technologies for disposable rapid tests and lab-on-a-chip diagnostics. Its rapid tests include immunoassays designed to detect proteins associated with biomarkers, allergens, or infectious diseases, including Covid-19; these can be paired with Gentag technology for mobile, on-the-go testing. Disposable lab-on-a-chip systems can be combined with low-cost ASIC sensors for smartphone-enabled, on-the-spot diagnostics. Gentag states that it holds early-issued patents relating to wireless fever-monitoring patches, rapid tests, and smartphone-based DNA or RNA diagnostics. Through these wearable and connected testing solutions, the company aims to make health monitoring more accessible and improve drug compliance.